Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	Feb 27, 2026	FORM 4
8-K	Feb 26, 2026	8-K
424B5	Feb 26, 2026	424B5
144	Feb 25, 2026
FWP	Feb 25, 2026	FWP
424B5	Feb 24, 2026	424B5
8-K	Feb 19, 2026	8-K
SCHEDULE 13G/A	Feb 17, 2026
SCHEDULE 13G	Feb 17, 2026
SCHEDULE 13G	Feb 12, 2026
SCHEDULE 13G/A	Feb 5, 2026
4	Feb 4, 2026	FORM 4
4	Feb 4, 2026	FORM 4
4	Feb 4, 2026	FORM 4
4	Feb 4, 2026	FORM 4
4	Feb 4, 2026	FORM 4
4	Jan 26, 2026	FORM 4
4	Jan 26, 2026	FORM 4
144	Jan 22, 2026
144	Jan 22, 2026
4	Jan 20, 2026	FORM 4
144	Jan 15, 2026
8-K	Jan 12, 2026	8-K
4	Dec 29, 2025	FORM 4
4	Dec 29, 2025	FORM 4

← Newer Page 5 of 11 · 263 filings Older →